Matches in Nanopublications for { ?s ?p "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_assertion description "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073341.RABGXNsI1cd2eJHrRfoKsPf2OJhPVbslFkD2VdArqyKxk130_provenance.
- NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_assertion description "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_provenance.
- assertion description "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP750192.RAuz-Cxa1mSewK6ifFZYXTYX3rUkL2LwQdCF0E1iy_Vas130_assertion description "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750192.RAuz-Cxa1mSewK6ifFZYXTYX3rUkL2LwQdCF0E1iy_Vas130_provenance.
- NP1073340.RAlAx8-URkK0BVO5q9Wx3UdGWg01RI-_U3jioyi1Ky6eY130_assertion description "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073340.RAlAx8-URkK0BVO5q9Wx3UdGWg01RI-_U3jioyi1Ky6eY130_provenance.